Metastasis suppressor 1 controls osteoblast differentiation and bone homeostasis through regulating Src-Wnt/β-catenin
Meng Chen1, Liying Shan1, Ying Gan1
1NHC Key Lab of Hormones and Development, Tianjin Key Lab of Metabolic Diseases, Chu Hsien-I Memorial Hospital & Institute of Endocrinology, Tianjin Medical University, 6 Huan-Rui-Bei Road, Tianjin, 300134, China.
Abstract:
Metastasis suppressor 1 (MTSS1) plays an inhibitory role in tumorigenesis and metastasis of a variety of cancers. To date, the function of MTSS1 in the differentiation of marrow stromal progenitor cells remains to be explored. In the current study, we investigated whether and how MTSS1 has a role in osteoblast differentiation and bone homeostasis. Our data showed that MTSS1 mRNA was upregulated during osteoblast differentiation and downregulated in the osteoblastic lineage cells of ovariectomized and aged mice. Functional studies revealed that MTSS1 promoted the osteogenic differentiation from marrow stromal progenitor cells. Mechanistic explorations uncovered that the inactivation of Src and afterward activation of canonical Wnt signaling were involved in osteoblast differentiation induced by MTSS1. The enhanced osteogenic differentiation induced by MTSS1 overexpression was attenuated when Src was simultaneously overexpressed, and conversely, the inhibition of osteogenic differentiation by MTSS1 siRNA was rescued when the Src inhibitor was supplemented to the culture. Finally, the in vivo transfection of MTSS1 siRNA to the marrow of mice significantly reduced the trabecular bone mass, along with the reduction of trabecular osteoblasts, the accumulation of marrow adipocytes, and the increase of phospho-Src-positive cells on the trabeculae. No change in the number of osteoclasts was observed. This study has unraveled that MTSS1 contributes to osteoblast differentiation and bone homeostasis through regulating Src-Wnt/β-catenin signaling. It also suggests the potential of MTSS1 as a new target for the treatment of osteoporosis.
Insights
Metastasis suppressor 1 (MTSS1) promotes osteoblast differentiation and bone homeostasis by regulating Src-Wnt/β-catenin signaling. This finding suggests MTSS1 as a potential therapeutic target for osteoporosis.
Area of Science:
- Cell Biology
- Bone Biology
- Molecular Biology
Background:
- Metastasis suppressor 1 (MTSS1) is known to inhibit cancer metastasis.
- The role of MTSS1 in marrow stromal progenitor cell differentiation and bone homeostasis is unexplored.
Purpose of the Study:
- To investigate the function of MTSS1 in osteoblast differentiation and bone homeostasis.
- To elucidate the underlying molecular mechanisms of MTSS1's action in bone biology.
Main Methods:
- Analysis of MTSS1 mRNA levels during osteoblast differentiation and in aged/ovariectomized mice.
- In vitro functional studies using marrow stromal progenitor cells.
- In vivo studies involving MTSS1 siRNA transfection in mice.
- Western blot analysis to assess Src and Wnt/β-catenin signaling pathway activation.
Main Results:
- MTSS1 mRNA was upregulated during osteoblast differentiation and downregulated in aged/ovariectomized mice.
- MTSS1 overexpression promoted osteogenic differentiation, while MTSS1 inhibition impaired it.
- MTSS1-induced osteoblast differentiation involved Src inactivation and canonical Wnt signaling activation.
- In vivo MTSS1 knockdown reduced bone mass, osteoblasts, and increased marrow adipocytes, without affecting osteoclasts.
Conclusions:
- MTSS1 plays a crucial role in promoting osteoblast differentiation and maintaining bone homeostasis.
- The mechanism involves the regulation of the Src-Wnt/β-catenin signaling pathway.
- MTSS1 represents a potential therapeutic target for osteoporosis treatment.
Related Concept Videos
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Osteoclasts in Bone Remodeling
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
Bone Remodeling


